|
|
|
|
|
MedChem 2007 - New Drugs and Drug Candidates:
Recent Achievements in Medicinal Chemistry | | 26/10/2007 |
| 08:00 | Registration |
|
| 08:50 | Introduction |
|
| 09:00 | Nexavar - A Novel Inhibitor of Signal Transduction |
Dr Bernd RIEDL
(BAYER PHARMA, Wuppertal, Germany) |
| 09:50 | Design, Synthesis and Biological Activity of Therapeutics Targeting the PI3K Pathway |
Dr. Carlos GARCIA-ECHEVERRIA
(NOVARTIS PHARMA, Basel, Switzerland) |
| 10:40 | Coffee-break & poster session |
|
| 11:10 | Discovery of Sitagliptin and Other Novel DPP4 Inhibitors |
Dr Tesfaye BIFTU
(MERCK, Rahway, United States) |
| 12:00 | Hit-to-lead studies on Aminopropoxy phenyloxazolines. Discovery of a novel class of potent H3R ligands for the treatment of cognitive dysfunction
|
(EYEDPHARMA) |
| 12:20 | Sandwich lunch & posters |
|
| 13:40 | Dual NK3/NK1 Receptor Antagonism: A Novel Approach for the Treatment of Psychotic Disorders |
Dr. Patrick SCHNIDER
(F. HOFFMANN-LA ROCHE, Basel, Switzerland) |
| 14:30 | Isoindolinones as promising inhibitors of the MDM2-P53 protein-protein interaction |
Dr. Eric VALEUR
(MERCK SERONO, Chilly Mazarin, France) |
| 14:50 | ETHR inhibitors as TB drug boosters: A new strategy to fight tuberculosis |
Prof. Nicolas WILLAND
(UNIVERSITY OF LILLE, Lille, France) |
| 15:10 | Coffee-break & poster session |
|
| 15:40 | Discovery of R256918 a Gut-Selective MTP Inhibitor to Treat Obesity |
Dr Lieven MEERPOEL
(JOHNSON & JOHNSON PRD, Beerse, Belgium) |
| 16:30 | Inhibitors of Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) |
Dr Mark BUNNAGE
(PFIZER, Boston, United States) |
| 17:20 | Closing remarks |
|
| <Previous page |
|
|
|
